# Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing

> **NCT05520788** · — · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Biliary Tract Cancer

## Interventions

- **GENETIC:** precise medicine

## Key facts

- **NCT ID:** NCT05520788
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05520788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05520788, "Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05520788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*